Sintx Technologies, Inc.
SINTNASDAQHealthcareMedical - Devices
Previous close
$1.55
+$0.04 · +2.65%
Pre-market
$1.51
−$0.04 · -2.58%
Aug 24, 7:00 AM ET
SINT company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
23
Expensive
Momentum
17
Strong Down
Sentiment
57
Mixed
Risk resilience
29
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Eric K. Olson
- Listed since
- Feb 13, 2014
- Employees
- 32
Market position
Day range
Current $1.55
52-week range
Current $1.55
- Open
- $1.55
- Previous close
- $1.51
- Volume
- 25.47K
- 0.28× average
- Average volume
- 92.29K
- Average daily volume
- Market cap
- 9.85M USD
- Beta
- 0.64
- Market reference 1
- 50-day average
- $1.7412
- -10.98% below average
- 200-day average
- $2.6804
- -42.17% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 9.81M USD
- P/E (TTM)
- -0.28×
- P/B (TTM)
- 1.56×
- P/S (TTM)
- 7.14×
- EV / EBITDA
- -1.02×
- Earnings yield
- -159.57%
- Free cash flow yield
- -81.82%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- -4.63%
- Operating margin
- -852.14%
- Net margin
- -1303.40%
- Return on equity
- -583.24%
- Return on assets
- -179.71%
- Return on invested capital
- -173.54%
Financial health
- Debt / equity
- 0.63×
- Current ratio
- 1.51×
Earnings
- EPS beat rate
- 36%
- 4 beats, 7 misses, 0 met estimates
- Average EPS surprise
- -44.65%
- 11 comparable reports
- Latest EPS result
- -0.75
- Estimate -0.73 · Miss by 2.74%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
SINT peers
ETFs holding SINT
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research SINTresearch.disclaimer